| Literature DB >> 30347938 |
Ji Min Choi1, Jong In Yang1, Seung Joo Kang1, Yoo Min Han1, Jooyoung Lee1, Changhyun Lee1, Su Jin Chung1, Dae Hyun Yoon2, Boram Park1, Yong Sung Kim3.
Abstract
BACKGROUND/AIMS: The different clinical manifestations of gastroesophageal reflux disease (GERD) may be influenced by associated psychological factors. We evaluated the psychological status (anxiety and depression) according to each subtype of GERD.Entities:
Keywords: Anxiety; Depression; Gastroesophageal reflux; Psychology
Year: 2018 PMID: 30347938 PMCID: PMC6175551 DOI: 10.5056/jnm18069
Source DB: PubMed Journal: J Neurogastroenterol Motil ISSN: 2093-0879 Impact factor: 4.924
Figure 1Study population. EGD, esophagogastroduodenoscopy; FGID, functional gastrointestinal disorder; AEE, asymptomatic erosive esophagitis; NERD, non-erosive reflux disease; ERD, erosive reflux disease.
Baseline Characteristics of Different Subgroups of Gastroesophageal Reflux Disease
| Control (n = 16 157) | ERD (n = 176) | NERD (n = 1398) | AEE (n = 1368) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
| ||||||||
| OR (95% CI) | OR (95% CI) | OR (95% CI) | ||||||||
| Age (yr) | 48.9 ± 11.1 | 45.8 ± 10.9 | 0.97 (0.96–0.99) | < 0.001 | 47.0 ± 11.5 | 0.98 (0.98–0.99) | < 0.001 | 48.5 ± 11.1 | 1.00 (0.99–1.00) | 0.224 |
| Sex (female) | 6029 (37.3) | 25 (14.2) | 0.28 (0.18–0.43) | < 0.001 | 593 (42.4) | 1.24 (1.11–1.38) | < 0.001 | 158 (11.5) | 0.22 (0.18–0.26) | < 0.001 |
| BMI (kg/m2) | 23.6 ± 3.0 | 25.5 ± 3.2 | 1.21 (1.16–1.27) | < 0.001 | 23.7 ± 3.2 | 1.01 (0.99–1.03) | 0.290 | 25.1 ± 3.0 | 1.17 (1.15–1.19) | < 0.001 |
| Questionnaire | ||||||||||
| Diabetes history | 911 (5.6) | 6 (3.4) | 0.59 (0.26–1.34) | 0.207 | 49 (3.5) | 0.61 (0.45–0.81) | < 0.001 | 107 (7.8) | 1.42 (1.15–1.75) | < 0.001 |
| Current smoking | 8179 (50.6) | 138 (78.4) | 3.54 (2.47–5.08) | < 0.001 | 730 (52.2) | 1.07 (0.96–1.19) | 0.252 | 1021 (74.6) | 2.87 (2.53–3.25) | < 0.001 |
| Alcohol use | 11 272 (69.8) | 153 (86.9) | 2.88 (1.86–4.47) | < 0.001 | 961 (68.7) | 0.95 (0.85–1.07) | 0.424 | 1170 (85.5) | 2.56 (2.20–2.99) | < 0.001 |
| Marriage status | 14 882 (92.1) | 144 (81.8) | 0.39 (0.26–0.57) | < 0.001 | 1215 (86.9) | 0.57 (0.48–0.67) | < 0.001 | 1253 (91.6) | 0.93 (0.77–1.14) | 0.498 |
| Aspirin use | 1908 (11.8) | 15 (8.5) | 0.70 (0.41–1.18) | 0.181 | 156 (11.2) | 0.94 (0.79–1.12) | 0.469 | 206 (15.1) | 1.32 (1.13–1.55) | < 0.001 |
| NSAID use | 1190 (7.4) | 7 (4.0) | 0.52 (0.24–1.11) | 0.092 | 108 (7.7) | 1.05 (0.86–1.29) | 0.622 | 116 (8.5) | 1.17 (0.96–1.42) | 0.132 |
| Seropositive | 8593 (53.2) | 44 (25.0) | 0.29 (0.21–0.41) | < 0.001 | 692 (49.5) | 0.86 (0.77–0.96) | 0.008 | 393 (28.7) | 0.35 (0.31–0.40) | < 0.001 |
| Endoscopic findings | ||||||||||
| Atrophic gastritis | 5288 (32.7) | 30 (17.0) | 0.42 (0.29–0.63) | < 0.001 | 363 (26.0) | 0.72 (0.64–0.82) | < 0.001 | 345 (25.2) | 0.69 (0.61–0.79) | < 0.001 |
| Intestinal metaplasia | 2484 (10.3) | 12 (6.8) | 0.60 (0.33–1.07) | 0.085 | 105 (7.5) | 0.66 (0.54–0.81) | < 0.001 | 101 (7.4) | 0.65 (0.53–0.80) | < 0.001 |
ERD, erosive reflux disease; NERD, non-erosive reflux disease; AEE, asymptomatic erosive esophagitis; BMI, body mass index.
Values are presented as mean ± SD or n (%).
Figure 2Psychological scores of different subtypes of gastroesophageal reflux disease (GERD). (A) Scores of state anxiety (State-Trait Anxiety Inventory [STAI]-X1) (B) Scores of trait anxiety (STAI-X2) (C) Scores of depression (Beck Depression Inventory [BDI]). ERD, erosive reflux disease; NERD, non-erosive reflux disease; AEE, asymptomatic erosive esophagitis.
Multinomial Logistic Regression Analysis of Variables Associated With Subtypes of Gastroesophageal Reflux Disease
| Control | ERD | NERD | AEE | ||||
|---|---|---|---|---|---|---|---|
|
|
|
| |||||
| OR (95% CI) | OR (95% CI) | OR (95% CI) | |||||
| Age | 1.00 | 1.01 (0.99–1.02) | 0.495 | 1.00 (0.99–1.00) | 0.157 | 1.00 (1.00–1.01) | 0.524 |
| Sex (female) | 1.00 | 0.68 (0.39–1.18) | 0.168 | 1.42 (1.20–1.69) | < 0.001 | 0.38 (0.31–0.48) | < 0.001 |
| BMI | 1.00 | 1.18 (1.13–1.24) | < 0.001 | 1.04 (1.02–1.06) | < 0.001 | 1.12 (1.09–1.14) | < 0.001 |
| Current smoking | 1.00 | 2.28 (1.47–3.55) | < 0.001 | 1.37 (1.18–1.59) | < 0.001 | 1.46 (1.26–1.70) | < 0.001 |
| Alcohol use | 1.00 | 1.44 (0.88–2.34) | 0.144 | 0.96 (0.83–1.10) | 0.531 | 1.25 (1.05–1.49) | 0.012 |
| Marriage status | 1.00 | 0.45 (0.27–0.74) | 0.002 | 0.71 (0.58–0.87) | < 0.001 | 0.96 (0.76–1.22) | 0.728 |
| Diabetes mellitus | 1.00 | 0.51 (0.22–1.18) | 0.116 | 0.65 (0.48–0.87) | 0.004 | 1.13 (0.91–1.41) | 0.269 |
| Aspirin use | 1.00 | 0.80 (0.43–1.49) | 0.480 | 1.00 (0.80–1.25) | 0.993 | 1.11 (0.91–1.36) | 0.310 |
| NSAID use | 1.00 | 0.59 (0.25–1.40) | 0.230 | 1.19 (0.92–1.53) | 0.180 | 0.93 (0.73–1.19) | 0.567 |
| 1.00 | 0.32 (0.23–0.46) | < 0.001 | 0.96 (0.86–1.08) | 0.540 | 0.36 (0.31–0.40) | < 0.001 | |
| Atrophic gastritis | 1.00 | 0.55 (0.35–0.87) | 0.010 | 0.88 (0.76–1.02) | 0.084 | 0.80 (0.69–0.93) | 0.003 |
| Intestinal metaplasia | 1.00 | 1.10 (0.58–2.11) | 0.763 | 0.79 (0.64–0.99) | 0.038 | 0.84 (0.67–1.06) | 0.147 |
| State anxiety | 1.00 | 2.20 (1.27–3.81) | 0.005 | 1.89 (1.53–2.33) | < 0.001 | 1.25 (0.96–1.65) | 0.103 |
| Trait anxiety | 1.00 | 1.07 (0.44–2.59) | 0.882 | 1.78 (1.34–2.35) | < 0.001 | 1.27 (0.83–1.96) | 0.270 |
| Depression | 1.00 | 2.23 (1.18–4.22) | 0.013 | 2.21 (1.75–2.80) | < 0.001 | 1.29 (0.93–1.80) | 0.132 |
ERD, erosive reflux disease; NERD, non-erosive reflux disease; AEE, asymptomatic erosive esophagitis; BMI, body mass index.